Impact of aberrant myeloid antigen expression on outcomes of patients with t-cell acute lymphoblastic leukemia

Mohamed, Al Zaabi; Murtadha, Al Khabori; Naglaa, Fawaz; Sulayma, Al Lamki; Arwa, Al Riyami; Mohammed, Al Huneini; Muhanna, Al Muslahi; Salam, Alkindi.

Oman Medical Journal. 2017; 32 (3): 189-193

in English | IMEMR | ID: emr-187846

ABSTRACT

Objectives:

To evaluate the impact of myeloid antigen expression on complete remission [CR], event-free survival [EFS], and overall survival [OS] in patients with T-cell acute lymphoblastic leukemia [T-ALL] treated with intensive chemotherapy

Search on Google

Index: IMEMR (Eastern Mediterranean) Language: English Journal: Oman Med. J. Year: 2017

MEDLINE

LILACS

LIS

Search on Google

Index: IMEMR (Eastern Mediterranean) Language: English Journal: Oman Med. J. Year: 2017